Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Researchers from LMU University publish new studies and findings in the area of breast cancer
January 15th, 2009
"Differences in overall survival (OS) and disease-free survival (DFS) between patients with invasive ductal (IDC) and invasive lobular breast cancer (ILC) are controversial. The study population was selected from a database of 5,689 female patients with invasive breast cancer," researchers in Munich, Germany report. "In order to focus on the impact of tumour histology, all primary metastatic patients and patients with adjuvant chemotherapy or anti-hormonal treatment were excluded. Only patients with pure invasive lobular and invasive ductal histology were included. Multivariate survival analyses of 2,058 eligible patients confirmed tumour histology as an independent...
Source: Women's Health Weekly (2009-01-15)
|
